Latest Conference Articles

With the rapid pace of change in biosimilar payer benefit design, efforts to stay regularly updated on policy changes ahead of time become critical for patient care.

Even before the pandemic, pharmacists were playing a really important role in public health, being one of the most accessible health care providers.

Experts discuss the pros and cons of using oral azacytidine to treat patients with acute myeloid leukemia.

With a lack of head-to-head studies comparing combination regimens in frontline metastatic renal cell carcinoma, deciding on how to choose the right regimen can pose a challenge.

Pharmacies have a lot of opportunities to think out of the box, to be innovative, and continue to drive that power of community that we're highlighting at the event here.

Being able to acknowledge those missteps that may have been made that may have prevented you from delivering as culturally competent care, and being able to recalibrate and to take the correction is an important step.

Ryan Burke, PharmD, director of professional affairs at Pharmacy Technician Certification Board, discusses more advanced roles for pharmacy technicians and how they can continue to grow beyond their current roles.

Pursuing the expanded access process for treatment may be the best option for patients who have exhausted all available FDA-approved drugs and clinical trials.

Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how the COVID-19 pandemic has changed the role of pharmacy technicians and what is expected as we move forward.

Cultural competence should be thought in terms of being cognizant that there are differences in every single patient.

CS Family Pharmacy has migrated to a combo-type pharmacy, integrating long term care.

Bunch Pharmacy has been in business for 24 years in the rural area of Alabama.

Vibhuti Arya Amirfar, PharmD, MPH, discusses building individual and systems resilience to dismantle structural racism in the pharmacy field.

Experts discuss tools and trainings that health care institutions have established during the pandemic to support hematology-oncology pharmacists who are struggling with wellness and mental health challenges.

The American Diabetes Association guidelines have self-care and lifestyle recommendations for patients and health care professionals.

Learning the Pharmacists' Patient Care Process steps and being mindful or internalizing those can help set best practices for pharmacy team members.

Health Mart also presented the first ever Innovation Award at McKesson ideaShare 2022.

Lifestyle modifications are the cornerstone of treatment.

Emphasizing the accessible nature of pharmacies and why this is essential for patients can help legislators and others understand why changes are necessary.

Harnessing the current momentum and engaging with legislators is crucial for the pharmacy industry to grow and expand.

A lot of recent studies have focused on how to teach students and residents the Pharmacists' Patient Care Process (PPCP) and how pharmacists are already engaging with the PPCP.

These clear-cut guidelines help pharmacists making sure the patients are getting the right drug to set them up for success and prevent problems down the road.

Pharmacists are already doing a lot of things with the Pharmacists' Patient Care Process, but they haven't always used that language.

The future trend in managing diabetes will extend into glycemic control, weight reduction, and renal liver, for example.

Women in pharmacy must realize that what they have to offer has value, both to the business and to patients’ lives.

Finding the time to improve payer performance can be a major hurdle but designating even 30 minutes per week can make a difference.

The Pharmacist Patient Care Process provides really consistent language for pharmacists and pharmacy team members to talk about what teams are already doing.

Simple changes to each day can improve motivation and wellness for pharmacists.

Christine Walko, PharmD, BCOP, FCCP, discusses some new developments for PARP inhibitors in cancer care for patients with homologous recombination deficiency.

In February of this year, the new statistics came out where we're at now 37 million with diabetes and 96 million with prediabetes.